FDA clears Ziosoft CT brain perfusion application
Ziosoft, a provider of advanced visualization and analysis software for medical imaging, has received 510(k) clearance from the FDA for its CT brain perfusion application.
The company said its brain perfusion application is an analysis tool used with the Ziostation thin client system. The software can provide brain perfusion functionality to clinicians as a thin client application using standard commercial hardware. The software option aids radiologists in stroke assessment by providing a color map of cerebral blood flow and other perfusion-related parameters from CT images of the brain. The brain perfusion application includes image manipulation tools, as well as measurement tools, such as cerebral blood volume, blood flow and mean transit time.
Its brain perfusion application provides radiologists with decision support tools to assess the type and extent of cerebral perfusion disturbance whether viewed in a hospital or at a remote location, the Redwood City, Calif.-based Ziosoft said.
The company said its brain perfusion application is an analysis tool used with the Ziostation thin client system. The software can provide brain perfusion functionality to clinicians as a thin client application using standard commercial hardware. The software option aids radiologists in stroke assessment by providing a color map of cerebral blood flow and other perfusion-related parameters from CT images of the brain. The brain perfusion application includes image manipulation tools, as well as measurement tools, such as cerebral blood volume, blood flow and mean transit time.
Its brain perfusion application provides radiologists with decision support tools to assess the type and extent of cerebral perfusion disturbance whether viewed in a hospital or at a remote location, the Redwood City, Calif.-based Ziosoft said.